透過您的圖書館登入
IP:18.117.250.210
  • 期刊

三尖瓣逆流:過去、現在和可能的未來

摘要


三尖瓣在過去一直是被忽視的疾病,大部分的醫生都著重在左邊心臟的治療,認為只要將左邊心臟功能改善,三尖瓣及右心就會跟著進步。隨著越來越多證據顯示,殘留的三尖瓣逆流及右心衰竭會降低病人的存活率,近年來對三尖瓣的重視才越來越多,早期的介入、治療、扭轉右心衰竭的惡性循環,會是未來的趨勢。雖然目前治療指引大多著重在繼發性三尖瓣逆流根本原因的治療,隨著醫療技術的進步以及手術風險的下降,未來會有更多證據,相信早期的介入治療,無論是瓣環成形術或是經導管的緣對緣修補術,能夠提升三尖瓣閉鎖不全病患的存活率及生活品質。

參考文獻


Wang N, Fulcher J, Abeysuriya N, et al. Tricuspid regurgitation is associated with increased mortality independent of pulmonary pressures and right heart failure: a systematic review and meta-analysis. Eur Heart J 2019;40:476-84.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. J Am Coll Cardiol 2021;77:e25-e197.
Scotti A, Sturla M, Granada JF, et al. Outcomes of isolated tricuspid valve replacement: a systematic review and metaanalysis of 5,316 patients from 35 studies. EuroIntervention 2022;18:840-51.
Dreyfus J, Flagiello M, Bazire B, et al. Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes. Eur Heart J 2020; 41: 4304-17.
Praz F, Muraru D, Kreidel F, et al. Transcatheter treatment for tricuspid valve disease. EuroIntervention 2021;17:791-808.

延伸閱讀